Developer docs
API playgroundTry for free, no card

Search company profiles

Plasmapp

Full company profile

uuid0002zzu

Namestring
Plasmapp
Legal namestring
Plasmapp Co., Ltd.
Websiteurl
plasmapp.co.kr
Company typeenum
Public
Founded yearint
2014
Descriptiontext

Plasmapp Co., Ltd. is a South Korean bio-plasma deep-tech medical device company that develops low-temperature plasma technology for healthcare applications. Founded in 2014 and publicly listed on KOSDAQ under ticker 405000, the company has assembled a portfolio of 158 patent cases and obtained regulatory certifications from over 26 countries. Its technology platform addresses three application domains: biological inactivation (sterilization), regenerative activation (implants), and stimulative therapy (skin treatment). Plasmapp is headquartered in Seongnam-si, South Korea, and operates with 51-100 employees.

The company's commercial portfolio is organized around two principal brands. STERLINK is a modular family of low-temperature plasma sterilizers comprising premium models (FPS-15s Plus, mini, lab) and universal models (U420/lite, U510/lite+, Lite+) for hospitals, clinics, and laboratories. ACTILINK is a plasma regenerative activator for dental and medical implants. Revenue is generated primarily through hardware sales of these devices to medical institutions, with ophthalmology hospitals and clinics treated as the prioritized primary vertical. Distribution combines direct enterprise sales with a channel-partner network covering approximately 50 countries across the Americas, EMEA, and Asia Pacific. The most material commercial event in the company's recent history is a two-year exclusive supply agreement with DS Medical for 150 STERLINK Lite+ units, alongside entry into the U.S. ophthalmic healthcare market in late 2025.

Plasmapp's business model is hardware-centric and the company has historically been unprofitable, but management has executed significant operational restructuring—including outsourcing improvements, cost streamlining, and headcount adjustments—to reduce annual operating losses by more than 10 billion KRW and officially resolve its capital impairment status by early 2026. A 5 billion KRW capital increase from corporate investors Dreamtech and L&C Bio in December 2023 funded new device development, production transfer, and growth with minimal capex. Leadership is anchored by founder and CEO Youbong Lim, with Sun Gyu Kim serving as Chief Marketing Officer.

Short descriptiontext

Plasmapp Co., Ltd. is a South Korean KOSDAQ-listed (405000) bio-plasma deep-tech medical device company that develops low-temperature plasma sterilization (STERLINK) and regenerative activation (ACTILINK) systems for hospitals, ophthalmology clinics, and implant providers across approximately 50 countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersDaejeon, South Korea
HQ citystring
Daejeon
HQ countrystring
South Korea
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
low temperature plasma sterilization, medical device sterilization, plasma regenerative activation, ophthalmic sterilization equipment, medical plasma technology
Industry2 codes
PRIMARYHLAFAEAE
Home Infusion Therapy Providers
SECONDARYHLAAAAAI
Plasma-Derived Therapeutics (immunoglobulins, albumin, clotting factors)
Healthcare & Life Sciences/Biotechnology & Biologics/Therapeutic Biologics (mAbs, recombinant proteins, cytokines)
NAICS code2 codes
  • Surgical and Medical Instrument Manufacturing339112
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Medical Device Sterilization Equipment
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Medical Device Sales (STERLINK & ACTILINK)
TypeHardware Sales
Description

Plasmapp generates revenue primarily through the sale of medical devices including low-temperature plasma sterilizers (STERLINK line) and plasma regenerative activators (ACTILINK). The company manufactures and sells sterilizers to medical institutions including ophthalmology hospitals and clinics.

plasmapp.com
2Capital Increase for Growth
TypeOne Time License
Description

Plasmapp raised 5 billion won through capital increase to fund development of new devices, transfer of production, and support increasing sales with minimal CAPEX. The company plans to achieve quarterly breakeven within 2024 through internal restructuring.

pharmnews.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Operations, Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 2 records shown
1STERLINK
Description

Low Temperature Plasma Sterilizer product line including STERLINK FPS-15s Plus, STERLINK mini, STERLINK lab, STERLINK U420/lite, STERLINK U510/lite+

plasmapp.com
+1 more record
Core offering1 text field

Plasmapp develops, manufactures, and sells low-temperature plasma-based medical devices, primarily the STERLINK line of plasma sterilizers (premium and universal models) for hospitals, ophthalmology clinics, and laboratories, and the ACTILINK line of plasma regenerative activators for dental and medical implant procedures. The company also sells related accessories and provides customized sterilization/regeneration solutions to medical institutions in approximately 50 countries.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Reduced annual operating losses by more than 10 billion won over the past year
+2 more records
Product overview1 text field

Plasmapp is a bio-plasma deep-tech company offering two core product lines: STERLINK (low-temperature plasma sterilizers) and ACTILINK (plasma regenerative activators for implants). The STERLINK line includes premium models (FPS-15s Plus, mini, lab) and universal models (U420/lite, U510/lite+, Lite+), designed for medical facility sterilization with applications spanning ophthalmology, general surgery, and laboratory settings. The ACTILINK motion/reborn provides regenerative activation technology for medical implants. The company holds 158 patents and certifications from over 26 countries.

Product and service7 records
1STERLINK FPS-15s Plus
CategoryLow Temperature Plasma Sterilizer (Premium Line)
Description

Premium line low-temperature plasma sterilizer for medical facility sterilization, designed for hospitals and clinics requiring chemical-free, low-temperature sterilization of medical devices.

2STERLINK mini
CategoryLow Temperature Plasma Sterilizer (Premium Line)
Description

Compact premium line low-temperature plasma sterilizer suitable for smaller medical facilities needing effective plasma sterilization in a reduced footprint.

3STERLINK lab
CategoryLow Temperature Plasma Sterilizer (Premium Line)
Description

Laboratory-grade low-temperature plasma sterilizer in the premium line, intended for research and clinical laboratory settings requiring plasma-based sterilization.

4STERLINK U420/lite
CategoryLow Temperature Plasma Sterilizer (Universal Line)
Description

Universal line low-temperature plasma sterilizer offering cost-effective plasma sterilization for a range of medical applications and healthcare providers.

5STERLINK U510/lite+
CategoryLow Temperature Plasma Sterilizer (Universal Line)
Description

Universal line low-temperature plasma sterilizer with enhanced features, applicable to ophthalmology and general medical sterilization use cases.

6STERLINK Lite+
CategoryLow Temperature Plasma Sterilizer (Ophthalmology Variant)
Description

Low-temperature plasma sterilizer variant specifically designed for ophthalmology hospitals and clinics, delivered under a two-year exclusive supply contract with DS Medical for the Korean and U.S. ophthalmic markets.

7ACTILINK motion/reborn
CategoryPlasma Regenerative Activator for Implants
Description

Plasma regenerative activator for dental and medical implants, leveraging plasma-based biological regeneration and activation technology to improve implant integration and healing outcomes for implantology professionals.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
1DS Medical
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-03-20
Description

DS Medical entered into a two-year exclusive supply contract with Plasmapp for 150 units of STERLINK Lite+ low-temperature plasma sterilizers to be delivered to ophthalmology hospitals and clinics. This partnership represents Plasmapp's key distribution channel for its ophthalmology-focused sterilization products in the Korean market.

newstopkorea.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Steris is a global leader in sterilization and infection prevention, offering low-temperature hydrogen peroxide sterilization systems (V-PRO) that directly compete with Plasmapp's STERLINK plasma sterilizers in hospital and surgical center settings. Comparable as the dominant incumbent in medical device sterilization.

2Johnson & Johnson (Advanced Sterilization Products)
TypeBroad incumbent
Description

ASP, a J&J subsidiary, markets the Sterrad system, the most widely adopted low-temperature hydrogen peroxide plasma sterilizer globally. Directly comparable as a competing low-temperature sterilization modality targeted at the same ophthalmology, surgical, and hospital customers.

TypeBroad incumbent
Description

Getinge is a major medical technology company offering steam and low-temperature sterilization solutions, including the Stericool hydrogen peroxide system. Comparable as a broad sterilization incumbent competing for the same hospital sterilization budgets as STERLINK.

TypeBroad incumbent
Description

Solventum provides sterilization monitoring and infection prevention products, and previously distributed the Attest hydrogen peroxide sterilization system through 3M. Comparable as a broad incumbent serving healthcare sterilization workflows with overlapping customer relationships.

TypeDirect peer
Description

Tuttnauer manufactures autoclaves and low-temperature sterilizers for hospitals, dental clinics, and laboratories, with a comparable mid-sized, multi-product sterilization portfolio. Directly competes with Plasmapp's STERLINK line across ambulatory surgery centers and ophthalmology/dental clinics.

TypeDirect peer
Description

Matachana is a European specialist in low-temperature sterilization using hydrogen peroxide and other chemistries, serving hospitals and research labs. Comparable as a focused low-temperature sterilization competitor targeting similar hospital and clinical customers as Plasmapp.

TypeDirect peer
Description

Steelco is an Italian manufacturer of sterilization, disinfection, and laboratory equipment for hospitals and pharmaceutical cleanrooms. Comparable as a direct mid-market sterilization equipment competitor with overlapping product categories to STERLINK.

8Shinva Medical Instrument
TypeRegional player
Description

Shinva is one of China's largest sterilization and medical equipment manufacturers, supplying autoclaves and plasma sterilizers primarily across Asia. Comparable as a regional low-temperature sterilization peer serving similar hospital and clinical customers, though predominantly in the Chinese market.

TypeDirect peer
Description

Cisa Group produces low-temperature sterilizers using hydrogen peroxide and peracetic acid for healthcare facilities, with comparable product positioning to STERLINK in hospital infection prevention.

10Renolit SE
TypeOthers
Description

Renolit supplies specialty films and surface treatment technologies used in medical device packaging and sterilization workflows. Relevant as an adjacent supplier/comparator in the broader medical plasma and surface treatment value chain overlapping with Plasmapp's plasma applications.

Market position
Strengths1 record

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds6 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors12 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1 record

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Plasmapp

Medical Device Sterilization Equipmentplasmapp.co.kr

Plasmapp Co., Ltd. is a South Korean KOSDAQ-listed (405000) bio-plasma deep-tech medical device company that develops low-temperature plasma sterilization (STERLINK) and regenerative activation (ACTILINK) systems for hospitals, ophthalmology clinics, and implant providers across approximately 50 countries.

What Plasmapp does

Plasmapp Co., Ltd. is a South Korean bio-plasma deep-tech medical device company that develops low-temperature plasma technology for healthcare applications. Founded in 2014 and publicly listed on KOSDAQ under ticker 405000, the company has assembled a portfolio of 158 patent cases and obtained regulatory certifications from over 26 countries. Its technology platform addresses three application domains: biological inactivation (sterilization), regenerative activation (implants), and stimulative therapy (skin treatment). Plasmapp is headquartered in Seongnam-si, South Korea, and operates with 51-100 employees.

The company's commercial portfolio is organized around two principal brands. STERLINK is a modular family of low-temperature plasma sterilizers comprising premium models (FPS-15s Plus, mini, lab) and universal models (U420/lite, U510/lite+, Lite+) for hospitals, clinics, and laboratories. ACTILINK is a plasma regenerative activator for dental and medical implants. Revenue is generated primarily through hardware sales of these devices to medical institutions, with ophthalmology hospitals and clinics treated as the prioritized primary vertical. Distribution combines direct enterprise sales with a channel-partner network covering approximately 50 countries across the Americas, EMEA, and Asia Pacific. The most material commercial event in the company's recent history is a two-year exclusive supply agreement with DS Medical for 150 STERLINK Lite+ units, alongside entry into the U.S. ophthalmic healthcare market in late 2025.

Plasmapp's business model is hardware-centric and the company has historically been unprofitable, but management has executed significant operational restructuring—including outsourcing improvements, cost streamlining, and headcount adjustments—to reduce annual operating losses by more than 10 billion KRW and officially resolve its capital impairment status by early 2026. A 5 billion KRW capital increase from corporate investors Dreamtech and L&C Bio in December 2023 funded new device development, production transfer, and growth with minimal capex. Leadership is anchored by founder and CEO Youbong Lim, with Sun Gyu Kim serving as Chief Marketing Officer.

Plasmapp firmographics

Firmographics
Name
Plasmapp
Legal name
Plasmapp Co., Ltd.
Website
https://plasmapp.co.kr
Company type
Public
Founded year
2014
Operating status
Operating
Headcount range
1–10 employees
Short description
Plasmapp Co., Ltd. is a South Korean KOSDAQ-listed (405000) bio-plasma deep-tech medical device company that develops low-temperature plasma sterilization (STERLINK) and regenerative activation (ACTILINK) systems for hospitals, ophthalmology clinics, and implant providers across approximately 50 countries.
Ownership category
akta.pro rank

Plasmapp industry classification

Industry
Product category
Medical Device Sterilization Equipment
NAICS
Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro industry
PRIMARYHLAFAEAE
Home Infusion Therapy Providers
SECONDARYHLAAAAAI
Plasma-Derived Therapeutics (immunoglobulins, albumin, clotting factors)
Healthcare & Life Sciences/Biotechnology & Biologics/Therapeutic Biologics (mAbs, recombinant proteins, cytokines)

Keywords

  • Low temperature plasma sterilization
  • Medical device sterilization
  • Plasma regenerative activation
  • Ophthalmic sterilization equipment
  • Medical plasma technology

Where Plasmapp is headquartered

Location

Headquarters

HQ city
Daejeon
HQ country
South Korea
HQ region
Asia

Offices1 record

Markets served

Plasmapp business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Operations, Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Infrastructure

Revenue model

  1. Medical Device Sales (STERLINK & ACTILINK): Plasmapp generates revenue primarily through the sale of medical devices including low-temperature plasma sterilizers (STERLINK line) and plasma regenerative activators (ACTILINK). The company manufactures and sells sterilizers to medical institutions including ophthalmology hospitals and clinics.
  2. Capital Increase for Growth: Plasmapp raised 5 billion won through capital increase to fund development of new devices, transfer of production, and support increasing sales with minimal CAPEX. The company plans to achieve quarterly breakeven within 2024 through internal restructuring.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Plasmapp product offering

Product offering

Core offering

Plasmapp develops, manufactures, and sells low-temperature plasma-based medical devices, primarily the STERLINK line of plasma sterilizers (premium and universal models) for hospitals, ophthalmology clinics, and laboratories, and the ACTILINK line of plasma regenerative activators for dental and medical implant procedures. The company also sells related accessories and provides customized sterilization/regeneration solutions to medical institutions in approximately 50 countries.

Product overview

Plasmapp is a bio-plasma deep-tech company offering two core product lines: STERLINK (low-temperature plasma sterilizers) and ACTILINK (plasma regenerative activators for implants). The STERLINK line includes premium models (FPS-15s Plus, mini, lab) and universal models (U420/lite, U510/lite+, Lite+), designed for medical facility sterilization with applications spanning ophthalmology, general surgery, and laboratory settings. The ACTILINK motion/reborn provides regenerative activation technology for medical implants. The company holds 158 patents and certifications from over 26 countries.

Differentiator

Problem solved

Functional benefit

Brands

  • STERLINK: Low Temperature Plasma Sterilizer product line including STERLINK FPS-15s Plus, STERLINK mini, STERLINK lab, STERLINK U420/lite, STERLINK U510/lite+
  • ACTILINK

Products and services

  • STERLINK FPS-15s Plus Premium line low-temperature plasma sterilizer for medical facility sterilization, designed for hospitals and clinics requiring chemical-free, low-temperature sterilization of medical devices.
  • STERLINK mini Compact premium line low-temperature plasma sterilizer suitable for smaller medical facilities needing effective plasma sterilization in a reduced footprint.
  • STERLINK lab Laboratory-grade low-temperature plasma sterilizer in the premium line, intended for research and clinical laboratory settings requiring plasma-based sterilization.
  • STERLINK U420/lite Universal line low-temperature plasma sterilizer offering cost-effective plasma sterilization for a range of medical applications and healthcare providers.
  • STERLINK U510/lite+ Universal line low-temperature plasma sterilizer with enhanced features, applicable to ophthalmology and general medical sterilization use cases.
  • STERLINK Lite+ Low-temperature plasma sterilizer variant specifically designed for ophthalmology hospitals and clinics, delivered under a two-year exclusive supply contract with DS Medical for the Korean and U.S. ophthalmic markets.
  • ACTILINK motion/reborn Plasma regenerative activator for dental and medical implants, leveraging plasma-based biological regeneration and activation technology to improve implant integration and healing outcomes for implantology professionals.

Quantifiable outcome

  • Reduced annual operating losses by more than 10 billion won over the past year
  • +2 more outcomes

Companies that use Plasmapp

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Plasmapp technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

Plasmapp partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • DS MedicalcoreChannel Partner/ Reseller/ Distributor · 20 March 2026DS Medical entered into a two-year exclusive supply contract with Plasmapp for 150 units of STERLINK Lite+ low-temperature plasma sterilizers to be delivered to ophthalmology hospitals and clinics. This partnership represents Plasmapp's key distribution channel for its ophthalmology-focused sterilization products in the Korean market.

Scale indicators8 records

Recent moves6 records

Expansion highlights5 records

Plasmapp competitors and assessment

Company assessment

Broad incumbents

  • Steris plc: Steris is a global leader in sterilization and infection prevention, offering low-temperature hydrogen peroxide sterilization systems (V-PRO) that directly compete with Plasmapp's STERLINK plasma sterilizers in hospital and surgical center settings. Comparable as the dominant incumbent in medical device sterilization.
  • Johnson & Johnson (Advanced Sterilization Products): ASP, a J&J subsidiary, markets the Sterrad system, the most widely adopted low-temperature hydrogen peroxide plasma sterilizer globally. Directly comparable as a competing low-temperature sterilization modality targeted at the same ophthalmology, surgical, and hospital customers.
  • Getinge: Getinge is a major medical technology company offering steam and low-temperature sterilization solutions, including the Stericool hydrogen peroxide system. Comparable as a broad sterilization incumbent competing for the same hospital sterilization budgets as STERLINK.
  • Solventum (formerly 3M Health Care): Solventum provides sterilization monitoring and infection prevention products, and previously distributed the Attest hydrogen peroxide sterilization system through 3M. Comparable as a broad incumbent serving healthcare sterilization workflows with overlapping customer relationships.

Direct peers

  • Tuttnauer: Tuttnauer manufactures autoclaves and low-temperature sterilizers for hospitals, dental clinics, and laboratories, with a comparable mid-sized, multi-product sterilization portfolio. Directly competes with Plasmapp's STERLINK line across ambulatory surgery centers and ophthalmology/dental clinics.
  • Matachana: Matachana is a European specialist in low-temperature sterilization using hydrogen peroxide and other chemistries, serving hospitals and research labs. Comparable as a focused low-temperature sterilization competitor targeting similar hospital and clinical customers as Plasmapp.
  • Steelco Group: Steelco is an Italian manufacturer of sterilization, disinfection, and laboratory equipment for hospitals and pharmaceutical cleanrooms. Comparable as a direct mid-market sterilization equipment competitor with overlapping product categories to STERLINK.
  • Cisa Group (Getinge affiliate): Cisa Group produces low-temperature sterilizers using hydrogen peroxide and peracetic acid for healthcare facilities, with comparable product positioning to STERLINK in hospital infection prevention.

Regional players

  • Shinva Medical Instrument: Shinva is one of China's largest sterilization and medical equipment manufacturers, supplying autoclaves and plasma sterilizers primarily across Asia. Comparable as a regional low-temperature sterilization peer serving similar hospital and clinical customers, though predominantly in the Chinese market.

Others

  • Renolit SE: Renolit supplies specialty films and surface treatment technologies used in medical device packaging and sterilization workflows. Relevant as an adjacent supplier/comparator in the broader medical plasma and surface treatment value chain overlapping with Plasmapp's plasma applications.

Market position

Strengths1 record

Weaknesses4 records

Competitive moat3 records

Customer concentration

Plasmapp social profiles

Digital presence

Plasmapp compliance and trust

Trust signal

Compliance1 record

Plasmapp financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Plasmapp leadership team

Management profile

Number of profiles

Profiles2 records

Plasmapp funding detail

Funding detail

Funding overview

Funding rounds6 records

Investors12 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Plasmapp M&A and investment

M&A and investment

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Plasmapp

What does Plasmapp do?

Plasmapp develops, manufactures, and sells low-temperature plasma-based medical devices, primarily the STERLINK line of plasma sterilizers (premium and universal models) for hospitals, ophthalmology clinics, and laboratories, and the ACTILINK line of plasma regenerative activators for dental and medical implant procedures. The company also sells related accessories and provides customized sterilization/regeneration solutions to medical institutions in approximately 50 countries.

Is Plasmapp a public or private company?

Plasmapp is a public company. It is classified as public and is currently operating.

When was Plasmapp founded?

Plasmapp was founded in 2014. It employs 1 to 10 people.

Where is Plasmapp based?

Plasmapp is headquartered in Daejeon, South Korea, in the Asia region.

How does Plasmapp make money?

Two revenue lines are on record. Medical Device Sales (STERLINK & ACTILINK) is the primary driver. The others are capital Increase for Growth.

Who are Plasmapp's main competitors?

Broad incumbents on record are Steris plc, Johnson & Johnson (Advanced Sterilization Products), Getinge and Solventum (formerly 3M Health Care). Direct peers are Tuttnauer, Matachana, Steelco Group and Cisa Group (Getinge affiliate). Shinva Medical Instrument is listed as a regional player. Renolit SE is listed as an others.

Does Plasmapp have an API?

No public API is recorded for Plasmapp.

What industry is Plasmapp in?

Plasmapp's product category is Medical Device Sterilization Equipment. Its primary akta.pro industry code is HLAFAEAE, Home Infusion Therapy Providers, with a secondary code of HLAAAAAI, Plasma-Derived Therapeutics (immunoglobulins, albumin, clotting factors). Its NAICS code is 339112 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
뉴스톱Plasmapp, shedding management items... resolving capital impairment status - NewstopKOSDAQ-listed medical device company Plasmapp has officially resolved its capital impairment status, eliminating the reason for its previous management item designation after submitting an audit report confirming fundamental financial structure improvements. The company reduced annual operating losses by more than 10 billion won over the past year through cost streamlining, outsourcing improvements, and organizational restructuring, achieving full escape from management items as of the end of last year. Plasmapp simultaneously secured a two-year exclusive supply contract with DS Medical to deliver 150 units of its STERLINK Lite+ low-temperature plasma sterilizer to ophthalmology hospitals and clinics.EIN PresswirePlasma Food Sterilizers Market to Reach USD 1,048 Mn by 2035 as Cold Plasma Technology Redefines Food Safety StandardsAccording to a Fact.MR report, the global plasma food sterilizers market is projected to grow from USD 631 million in 2025 to USD 1,048 million by 2035, representing a compound annual growth rate of 5.2%. The market growth is driven by increasing foodborne illness prevention initiatives and the shift toward chemical-free, energy-efficient cold plasma sterilization technology as an alternative to conventional heat or chemical methods. Key recent developments include Adtec Healthcare announcing a major funding round in July 2025 for global rollout of cold-plasma sterilization models, and Plasmapp launching its compact STERLINK™ FPS-15s Plus system in June 2024.KedglobalPlasmapp to export 12.3 mn worth of sterilizers to Japan - KED GlobalPlasmapp signed a 16.4 billion won ($12.3 million) sterilizer supply contract with Japanese distributors and dental companies. The overseas Sterlink Lite, launched in June, secured over 500 units in South Korea within two months. The product will debut at Yokohama's dental exhibition Sept. 27-30.MydailyHarry Bio successfully attracts investment with 'Harry Tugo', a global dental prosthetics brokerage platform.Heribio secured approximately 900 million won in investment from Plasmapp for its dental prosthetics brokerage platform, HERi2go. Plasmapp is participating as a strategic partner to collaborate on developing specialized sterilizers and expanding into the U.S. market, where Heribio has already established a local subsidiary. The company plans to leverage this funding to further establish its service in the U.S. and expand globally into Europe and South America.DealsiteMedical sterilizer 'Plasmap' completes pre-IPO investment.Plasmapp has completed a pre-IPO investment round, with investors focusing on the competitiveness of its ultra-fast low-temperature sterilizer and future expansion potential. The company's main product, STERLNK, is expanding its customer base among small and medium-sized clinics by offering rapid sterilization at a lower cost.